Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan;27(1):3-17.
doi: 10.1111/ene.14068. Epub 2019 Oct 22.

Systematic review of cognitive deficits in adult mitochondrial disease

H L Moore  1 , A P Blain  1 , D M Turnbull  1   2 , G S Gorman  1   2
Affiliations

Systematic review of cognitive deficits in adult mitochondrial disease

H L Moore et al. Eur J Neurol. 2020 Jan.

Abstract

The profile and trajectory of cognitive impairment in mitochondrial disease are poorly defined. This systematic review sought to evaluate the current literature on cognition in mitochondrial disease, and to determine future research directions. A systematic review was conducted, employing PubMed, Medline, Psycinfo, Embase and Web of Science, and 360-degree citation methods. English language papers on adult patients were included. The literature search yielded 2421 articles, of which 167 met inclusion criteria. Case reports and reviews of medical reports of patients yielded broad diagnoses of dementia, cognitive impairment and cognitive decline. In contrast, systematic investigations of cognitive functioning using detailed cognitive batteries identified focal cognitive rather than global deficits. Results were variable, but included visuospatial functioning, memory, attention, processing speed and executive functions. Conclusions from studies have been hampered by small sample sizes, variation in genotype and the breadth and depth of assessments undertaken. Comprehensive cognitive research with concurrent functional neuroimaging and physical correlates of mitochondrial disease in larger samples of well-characterized patients may discern the aetiology and progression of cognitive deficits. These data provide insights into the pattern and trajectory of cognitive impairments, which are invaluable for clinical monitoring, health planning and clinical trial readiness.

Keywords: adult; cognition; impairment; memory; mitochondrial disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no financial or other conflicts of interest.

Figures

Figure 1
Figure 1
Process implemented to identify papers for this systematic review.
See this image and copyright information in PMC

References

    1. Gorman GS, Schaefer AM, Ng Y, et al Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol 2015; 77: 753–759. - PMC - PubMed
    1. El‐Hattab AW, Adesina AM, Jones J, Scaglia F. MELAS syndrome: clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab 2015; 116: 4–12. - PubMed
    1. Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. Molecular pathology of MELAS and MERRF The relationship between mutation load and clinical phenotypes. Brain 1997; 120: 1713–1721. - PubMed
    1. Hirano M, Ricci E, Koenigsberger MR, et al Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord 1992; 2: 125–135. - PubMed
    1. Ozawa M, Goto YI, Sakuta R, Tanno Y, Tsuji S, Nonaka I. The 8,344 mutation in mitochondrial DNA: a comparison between the proportion of mutant DNA and clinicopathologic findings. Neuromuscul Disord 1995; 5: 483–488. - PubMed

Publication types